20-Hydroxyeicosatetraenoic acid
20-Hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid, an important polyunsaturated fatty acid in the human body. It is produced by the action of cytochrome P450 enzymes, specifically the CYP4A and CYP4F subfamilies. 20-HETE plays a significant role in the regulation of vascular tone, renal function, and blood pressure.
Biosynthesis[edit]
20-HETE is synthesized from arachidonic acid through the action of cytochrome P450 enzymes. These enzymes hydroxylate arachidonic acid at the omega-terminus, specifically at the 20th carbon, to produce 20-HETE. The CYP4A and CYP4F subfamilies are primarily responsible for this conversion.
Physiological roles[edit]
20-HETE is involved in various physiological processes:
- Vascular tone regulation: 20-HETE acts as a potent vasoconstrictor in the cerebral, renal, and coronary circulations. It modulates the activity of ion channels and smooth muscle contraction, influencing blood flow and pressure.
- Renal function: In the kidneys, 20-HETE regulates sodium and water excretion, affecting glomerular filtration rate and tubular reabsorption. It plays a role in renal autoregulation and blood pressure control.
- Inflammation and cell proliferation: 20-HETE has been implicated in inflammatory responses and cell proliferation, influencing processes such as angiogenesis and tumor growth.
Pathophysiological implications[edit]
Abnormal levels of 20-HETE have been associated with various diseases and conditions:
- Hypertension: Elevated 20-HETE levels have been linked to the development of hypertension, particularly in salt-sensitive individuals.
- Stroke and cardiovascular diseases: Due to its role in vascular tone regulation, 20-HETE is implicated in the pathogenesis of stroke and other cardiovascular diseases.
- Cancer: 20-HETE has been shown to promote tumor growth and metastasis in certain types of cancer, making it a potential target for therapeutic intervention.
Research and therapeutic potential[edit]
Research into 20-HETE is ongoing, with studies exploring its potential as a therapeutic target. Inhibitors of 20-HETE synthesis or action are being investigated for their potential to treat hypertension, stroke, and cancer.
Related pages[edit]
Gallery[edit]
-
Chemical structure of 20-HETE
20-Hydroxyeicosatetraenoic acid[edit]
-
Chemical structure of 20-Hydroxyeicosatetraenoic acid
